
// Phenotype library name
phenotype "Clinical Trial Criteria related to Cutaneous T-cell lymphoma" version "1";

// Phenotype library description 
description "Generated query for cancer treatment based on https://hemonc.org/wiki/Main_Page";

// # Referenced libraries #
include ClarityCore version "1.0" called Clarity;

documentset Docs:
    Clarity.createReportTypeList(["Clinical Trial Inclusion Criteria", "Clinical Trial Exclusion Criteria"]);

// Cancers

termset Condition_Terms_cutaneous_t_cell_lymphoma:[
    "primary cutaneous t-cell non-hodgkin lymphoma", "primary cutaneous t-cell non-hodgkin's lymphoma", "cutaneous t cell lymphoma", "pctcl", "cutaneous t-cell lymphoma", "skin t-cell non-hodgkin's lymphoma", "t-cell non-hodgkin's lymphoma of skin", "t-cell non-hodgkin's lymphoma of the skin", "cutaneous t-cell non-hodgkin lymphoma", "ctcl", "cutaneous t-cell non-hodgkin's lymphoma"
];

define final Condition_cutaneous_t_cell_lymphoma:
  Clarity.ProviderAssertion({
    termset:[Condition_Terms_cutaneous_t_cell_lymphoma],
    documentset:[Docs]
   }); 


// Regimen names

termset Regimen_Terms_Alemtuzumab_monotherapy:[
    "Alemtuzumab monotherapy"
];

define   Regimen_Alemtuzumab_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Alemtuzumab_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Lenalidomide_monotherapy:[
    "Lenalidomide monotherapy"
];

define   Regimen_Lenalidomide_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Lenalidomide_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Brentuximab_vedotin_monotherapy:[
    "Brentuximab vedotin monotherapy"
];

define   Regimen_Brentuximab_vedotin_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Brentuximab_vedotin_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Bendamustine_monotherapy:[
    "Bendamustine monotherapy"
];

define   Regimen_Bendamustine_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Bendamustine_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Methotrexate_monotherapy:[
    "Methotrexate monotherapy"
];

define   Regimen_Methotrexate_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Methotrexate_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Belinostat_monotherapy:[
    "Belinostat monotherapy"
];

define   Regimen_Belinostat_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Belinostat_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Bexarotene_monotherapy:[
    "Bexarotene monotherapy"
];

define   Regimen_Bexarotene_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Bexarotene_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Bexarotene_Pralatrexate:[
    "Bexarotene & Pralatrexate"
];

define   Regimen_Bexarotene_Pralatrexate:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Bexarotene_Pralatrexate],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Denileukin_diftitox_monotherapy:[
    "Denileukin diftitox monotherapy"
];

define   Regimen_Denileukin_diftitox_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Denileukin_diftitox_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Mogamulizumab_monotherapy:[
    "Mogamulizumab monotherapy"
];

define   Regimen_Mogamulizumab_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Mogamulizumab_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Pralatrexate_monotherapy:[
    "Pralatrexate monotherapy"
];

define   Regimen_Pralatrexate_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Pralatrexate_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Romidepsin_monotherapy:[
    "Romidepsin monotherapy"
];

define   Regimen_Romidepsin_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Romidepsin_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Vorinostat_monotherapy:[
    "Vorinostat monotherapy"
];

define   Regimen_Vorinostat_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Vorinostat_monotherapy],
    documentset:[Docs]
   }); 



// Results

        
define final CancerRegimen_cutaneous_t_cell_lymphoma:
    where Alemtuzumab_monotherapy_Regimen OR Lenalidomide_monotherapy_Regimen OR Brentuximab_vedotin_monotherapy_Regimen OR Bendamustine_monotherapy_Regimen OR Methotrexate_monotherapy_Regimen OR Belinostat_monotherapy_Regimen OR Bexarotene_monotherapy_Regimen OR Bexarotene_Pralatrexate_Regimen OR Denileukin_diftitox_monotherapy_Regimen OR Mogamulizumab_monotherapy_Regimen OR Pralatrexate_monotherapy_Regimen OR Romidepsin_monotherapy_Regimen OR Vorinostat_monotherapy_Regimen;
          
define final MatchedAllResults:
    where CancerRegimen_cutaneous_t_cell_lymphoma AND cutaneous_t_cell_lymphoma_Condition;
        
        

// Comments
/***

***/

